[First-time standard setting for therapy of pulmonary tuberculosis after revision of the Medical Treatment Standard--special reference to results of questionnaire survey on reality of early stage short-term PZA therapy and occurrence of the adverse effects].
D000995:Antitubercular Agents / Q000008:administration & dosage* / Q000009:adverse effects*; D056486:Chemical and Drug Induced Liver Injury; D004358:Drug Therapy / Q000592:standards*; D006073:Gout / Q000139:chemically induced / Q000453:epidemiology; D006801:Humans; D007564:Japan; D008107:Liver Diseases / Q000453:epidemiology; D011718:Pyrazinamide / Q000008:administration & dosage* / Q000009:adverse effects*; D011795:Surveys and Questionnaires; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*; D014527:Uric Acid / Q000097:blood
D000995:Antitubercular Agents; D014527:Uric Acid; D011718:Pyrazinamide